Detalhe da pesquisa
1.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
N Engl J Med
; 383(6): 546-557, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757523
2.
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
Mult Scler
; 28(8): 1229-1238, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34787005
3.
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Mult Scler
; 28(6): 910-924, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605319
4.
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
N Engl J Med
; 379(11): 1017-1027, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207920
5.
Consistent control of disease activity with fingolimod versus IFN ß-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.
J Neurol Neurosurg Psychiatry
; 91(1): 58-66, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467033
6.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.
J Neurol Neurosurg Psychiatry
; 91(5): 483-492, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132224
7.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet
; 387(10023): 1075-1084, 2016 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827074
8.
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
Int J Neurosci
; 126(1): 20-4, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-24007304
9.
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
Ther Adv Neurol Disord
; 17: 17562864241239453, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525490
10.
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Mov Disord
; 28(13): 1838-46, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23853029
11.
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
Neurol Ther
; 12(5): 1491-1515, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450172
12.
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.
Front Immunol
; 13: 852563, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35432382
13.
Verapamil attenuates the malignant treatment course in recurrent status epilepticus.
Epilepsy Behav
; 17(4): 565-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20189886
14.
Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies.
Acta Neuropathol
; 117(5): 535-44, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19277686
15.
Progressive multifocal leukoencephalopathy after fingolimod treatment.
Neurology
; 90(20): e1815-e1821, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669908
16.
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
Lancet Neurol
; 17(8): 689-698, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30001923
17.
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.
Ann Clin Transl Neurol
; 5(3): 346-356, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29560379
18.
A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo.
Mult Scler J Exp Transl Clin
; 3(3): 2055217317730096, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28989795
19.
Hemodynamic correlates of epileptiform discharges: an EEG-fMRI study of 63 patients with focal epilepsy.
Brain Res
; 1088(1): 148-66, 2006 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-16678803
20.
Stimulus and potassium-induced epileptiform activity in the human dentate gyrus from patients with and without hippocampal sclerosis.
J Neurosci
; 24(46): 10416-30, 2004 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-15548657